Biodistribution of the Radioprotective Drug 35 S-Labeled 3-Amino-2-Hydroxypropyl Phosphorothioate (WR77913)
- 1 April 1985
- journal article
- research article
- Published by JSTOR in Radiation Research
- Vol. 102 (1), 130-137
- https://doi.org/10.2307/3576436
Abstract
3-Amino-2-hydroxypropyl phosphorothioate (WR77913), a less toxic phosphorothioate radioprotector than WR2721 [S-2-(3-aminopropylamino)-ethyl phosphorothioic acid], was labeled with 35S. The biodistribution of a radioprotective dose of 800 mg/kg was determined in C3H mice bearing RIF-1 tumors as a function of time after i.p. injection and was expressed as percentage injected dose/gram (% ID/g). Levels of 35S in the blood peaked 10 min after injection, and radioactivity in most tissues was highest at 15 min. Label in most tissues declined markedly between 15 and 60 min, but in gut, salivary glands, tumor and brain, the levels of radioactivity remained quite stable over 1 h. At 30 min after injection the highest levels of labeled drug were found in submandibular salivary glands, gut, and kidney, with the lowest level in brain. Tumors had approximately the same amount of label as blood, muscle, skin and esophagus. Two principal differences between the distribution of label from WR77913 and WR2721 were defined. Although blood levels of 35S-WR2721 also peaked 10 min after injection, the 10-min blood levels achieved for WR77913 were > 4-fold greater than those attained by WR2721. Maximum levels of WR2721 occurred in most tissues 30-60 min after administration of the drug, compared to 15 min for WR77913. The basis for these differences remains to be determined, but these results suggest that the optimum interval between administration of WR77913 and irradiation may be shorter than for WR2721.This publication has 8 references indexed in Scilit:
- Radioprotection of Normal Tissues against Gamma Rays and Cyclotron Neutrons with WR-2721: LD 50 Studies and 35 S-WR-2721 BiodistributionRadiation Research, 1984
- Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatmentsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- The time course of radioprotection by WR 2721 in mouse skinInternational Journal of Radiation Oncology*Biology*Physics, 1982
- PROTEIN-BINDING OF N-2-MERCAPTOETHYL-1,3-DIAMINOPROPANE VIA MIXED DISULFIDE FORMATION AFTER ORAL-ADMINISTRATION OF WR27211982
- PROTECTIVE EFFECTS OF S-2-(3-AMINOPROPYLAMINO)ETHYLPHOSPHOROTHIOIC ACID AGAINST RADIATION-DAMAGE OF NORMAL-TISSUES AND A FIBRO-SARCOMA IN MICE1982
- Role of salivary mucins in the protection of the oral cavityJournal of Oral Pathology & Medicine, 1982
- Radioprotection of mouse skin by WR-2721 in single and fractionated treatmentsThe British Journal of Radiology, 1982
- Short-Term Radioprotective Effects of WR-2721 on the Rat Parotid GlandsRadiation Research, 1978